Diagst blood rare sera phenotyping test kit (Cw (RH8), Jka (JK1), Jkb (JK2), Lea (LE1), Leb (LE2), M (MNS1), N (MNS2), P1) - HSA Registration DE0016665
Access comprehensive regulatory information for Diagst blood rare sera phenotyping test kit (Cw (RH8), Jka (JK1), Jkb (JK2), Lea (LE1), Leb (LE2), M (MNS1), N (MNS2), P1) in the Singapore medical device market through Pure Global AI's free database. This CLASS D IVD medical device is registered under HSA registration number DE0016665 and owned by Diagast. The device was registered on December 22, 2014.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
Intended for the analysis of human biological specimens. They are used in the phenotyping of human red blood cells. The reagents are designed to determine the presence of antigens Cw (RH8), Jka (JK1), Jkb (JK2), Lea (LE1), Leb (LE2), M (MNS1), N (MNS2) and P1 on the surface of red blood cells.